The anticoagulant activity was evidenced by prolonged prothrombin time (98.9 s) and activated partial thromboplastin time (134.2 s at 11.5 mg/mL), and the antidiabetic activity was confirmed by the inhibition of α-amylase (EC50 = 104.8 μg/mL) and α-glucosidase (EC50 = 12.12 μg/mL) enzymes, as well as by a reduction in postprandial hyperglycemia in treated rats (400 mg/kg). Here, F2 is linked to Hyperglycemia.